- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Blau Farmaceutica SA (BLAU3)
Blau Farmaceutica SA stock price live, this page displays BVMF BLAU3 stock exchange data. View the BLAU3 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Blau Farmaceutica SA real time stock price chart below.
What Is the Blau Farmaceutica SA Stock Price Today?
The Blau Farmaceutica SA stock price today is 13.01.
What Is the Stock Symbol for Blau Farmaceutica SA?
The stock symbol for Blau Farmaceutica SA is "BLAU3."
What Stock Exchange Does Blau Farmaceutica SA Trade On?
Blau Farmaceutica SA is listed and trades on the B3 stock exchange.
Is Blau Farmaceutica SA a Good Stock to Buy?
Determining whether Blau Farmaceutica SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BLAU3 quote. (ISIN: BRBLAUACNOR8)
What Is the Blau Farmaceutica SA Stock Price Today?
The Blau Farmaceutica SA stock price today is 13.01.
What Is the Stock Symbol for Blau Farmaceutica SA?
The stock symbol for Blau Farmaceutica SA is "BLAU3."
What Stock Exchange Does Blau Farmaceutica SA Trade On?
Blau Farmaceutica SA is listed and trades on the B3 stock exchange.
Is Blau Farmaceutica SA a Good Stock to Buy?
Determining whether Blau Farmaceutica SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BLAU3 quote. (ISIN: BRBLAUACNOR8)
B3
Currency in BRL
13.01
-0.23(-1.74%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.94
13.22
52 wk Range
9.95
17.61
BLAU3 Scorecard
Full Analysis
Trading at a low Price / Book multiple
BLAU3 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
12.9413.22
52 wk Range
9.9517.61
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.78%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(3.78%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
BLAU3 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
16.73
Upside
+28.55%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Blau Farmaceutica Company Profile
Blau Farmacêutica S.A., a pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its medications cover various segments, such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and others. The company provides uterine stimulator; anesthetics; feminine health care; oncological products; antivirals and antiretrovirals; acid pump inhibitor; antithrombotic; antirheumatic; antibiotics; biopharmaceuticals; essential hospital products; biosimilars; hemoderivatives; and thrombolytics. It also offers biological drugs; oral and injectable drugs for treating cancer; specialized treatments for infectious diseases, special treatments, and others; and prescription and non-prescription drugs, including dermo-medicines, condoms, and others for retail and non-retail markets. In addition, the company provides blood products, biological, biotechnological, and antiretroviral drugs. It serves hospitals, private clinics, chemotherapy and hemodialysis centers, and public health institutions. The company was incorporated in 1987 and is headquartered in Cotia, Brazil.
Compare BLAU3 to Peers and Sector
Metrics to compare | BLAU3 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBLAU3PeersSector | |
|---|---|---|---|---|
P/E Ratio | 8.6x | −2.9x | −0.5x | |
PEG Ratio | 0.77 | 0.00 | 0.00 | |
Price/Book | 1.0x | 2.8x | 2.6x | |
Price / LTM Sales | 1.3x | 7.9x | 3.2x | |
Upside (Analyst Target) | 23.0% | 423.2% | 45.9% | |
Fair Value Upside | Unlock | 5.4% | 7.0% | Unlock |
Analyst Ratings
5 Buy
3 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 16.73
(+28.55% Upside)
Earnings
Latest Release
May 06, 2025
EPS / Forecast
0.51 / 0.33
Revenue / Forecast
373.00M / 406.68M
FAQ
What Is the Blau Farmaceutica (BLAU3) Stock Price Today?
The Blau Farmaceutica stock price today is 13.01.
What Stock Exchange Does Blau Farmaceutica Trade On?
Blau Farmaceutica is listed and trades on the B3 Stock Exchange stock exchange.
What Is the Stock Symbol for Blau Farmaceutica?
The stock symbol for Blau Farmaceutica is "BLAU3."
Does Blau Farmaceutica Pay Dividends? What’s The Current Dividend Yield?
The Blau Farmaceutica dividend yield is 3.78%.
What Is the Blau Farmaceutica Market Cap?
As of today, Blau Farmaceutica market cap is 2.31B.
What Is Blau Farmaceutica's Earnings Per Share (TTM)?
The Blau Farmaceutica EPS (TTM) is 1.50.
When Is the Next Blau Farmaceutica Earnings Date?
Blau Farmaceutica will release its next earnings report on 05 Aug 2025.
From a Technical Analysis Perspective, Is BLAU3 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Blau Farmaceutica Stock Split?
Blau Farmaceutica has split 0 times.
How Many Employees Does Blau Farmaceutica Have?
Blau Farmaceutica has 1900 employees.
What is the current trading status of Blau Farmaceutica (BLAU3)?
As of 14 Jul 2025, Blau Farmaceutica (BLAU3) is trading at a price of 13.01, with a previous close of 13.01. The stock has fluctuated within a day range of 12.94 to 13.22, while its 52-week range spans from 9.95 to 17.61.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.